Lin BioScience Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,589	1,488	3,261	1,645	806.85	1,092
Short-Term Investments	3,181	3,571	-	-	-	-
Trading Asset Securities	448.8	149.14	-	-	-	-
Cash & Short-Term Investments	5,219	5,208	3,261	1,645	806.85	1,092
Cash Growth	25.29%	59.71%	98.21%	103.91%	-26.13%	832.39%
Other Receivables	4.96	19.37	25.47	0.11	1.49	0.03
Receivables	4.96	19.37	25.47	0.11	1.49	0.03
Prepaid Expenses	111.72	123.27	137.69	-	-	-
Other Current Assets	1.42	0.35	0	27.01	11.21	17.11
Total Current Assets	5,337	5,351	3,424	1,672	819.54	1,109
Property, Plant & Equipment	40.5	50.66	58.91	65.86	5.4	7.55
Other Intangible Assets	104.58	118.4	108.91	108.92	97.12	100.23
Other Long-Term Assets	4.54	6.68	4.69	4.94	1.17	1.69
Total Assets	5,487	5,527	3,597	1,852	923.23	1,219
Accrued Expenses	97.51	120.82	111.47	59.16	44.94	26.39
Current Portion of Leases	14.6	16.1	13.85	10.32	2.24	2.91
Other Current Liabilities	17.49	18.4	13.38	10.39	423.07	277.33
Total Current Liabilities	129.6	155.33	138.7	79.88	470.25	306.63
Long-Term Leases	10.21	17.89	29.03	36.18	-	2.24
Total Liabilities	139.81	173.22	167.73	116.06	470.25	308.87
Common Stock	827.25	786.3	785.16	723.19	689.9	685
Additional Paid-In Capital	5,674	4,827	3,477	1,935	1,029	952.75
Retained Earnings	-3,533	-2,907	-2,162	-1,475	-1,162	-726.93
Comprehensive Income & Other	-128.68	148.35	37.34	51.55	-15.93	1.52
Total Common Equity	2,840	2,855	2,137	1,234	541.57	912.34
Minority Interest	2,507	2,499	1,292	501.86	-88.59	-2.35
Shareholders' Equity	5,347	5,354	3,429	1,736	452.98	909.99
Total Liabilities & Equity	5,487	5,527	3,597	1,852	923.23	1,219
Total Debt	24.81	33.99	42.87	46.5	2.24	5.15
Net Cash (Debt)	5,194	5,174	3,218	1,599	804.61	1,087
Net Cash Growth	25.82%	60.78%	101.30%	98.70%	-25.99%	2109.10%
Net Cash Per Share	64.89	65.83	43.50	22.29	11.70	17.50
Filing Date Shares Outstanding	82.73	78.63	78.52	72.32	68.99	68.5
Total Common Shares Outstanding	82.73	78.63	78.52	72.32	68.99	68.5
Working Capital	5,207	5,196	3,286	1,592	349.29	802.76
Book Value Per Share	34.33	36.31	27.22	17.07	7.85	13.32
Tangible Book Value	2,735	2,737	2,028	1,125	444.45	812.11
Tangible Book Value Per Share	33.06	34.80	25.84	15.56	6.44	11.86
Machinery	21.29	21.65	16.64	16.44	6.04	5.9
Leasehold Improvements	12.13	11.05	10.67	10.67	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.